GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Accord Medicines Corp Ltd (SZSE:000028) » Definitions » Price-to-Operating-Cash-Flow
中文

China National Accord Medicines (SZSE:000028) Price-to-Operating-Cash-Flow

: 6.51 (As of Today)
View and export this data going back to 1993. Start your Free Trial

As of today (2024-04-23), China National Accord Medicines's share price is ¥34.09. China National Accord Medicines's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was ¥5.24. Hence, China National Accord Medicines's Price-to-Operating-Cash-Flow Ratio for today is 6.51.

The historical rank and industry rank for China National Accord Medicines's Price-to-Operating-Cash-Flow or its related term are showing as below:

SZSE:000028' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 5.31   Med: 13.03   Max: 227.95
Current: 6.43

During the past 13 years, China National Accord Medicines's highest Price-to-Operating-Cash-Flow Ratio was 227.95. The lowest was 5.31. And the median was 13.03.

SZSE:000028's Price-to-Operating-Cash-Flow is ranked better than
77.46% of 71 companies
in the Medical Distribution industry
Industry Median: 14.09 vs SZSE:000028: 6.43

China National Accord Medicines's Cash Flow from Operations per share for the three months ended in Dec. 2023 was ¥2.62. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was ¥5.24.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of China National Accord Medicines was 14.60% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 25.00% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 14.70% per year.

During the past 13 years, China National Accord Medicines's highest 3-Year average Operating Cash Flow per Share Growth Rate was 138.50% per year. The lowest was -12.40% per year. And the median was 14.80% per year.


China National Accord Medicines Price-to-Operating-Cash-Flow Historical Data

The historical data trend for China National Accord Medicines's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Accord Medicines Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.65 13.07 9.57 5.50 5.50

China National Accord Medicines Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Operating-Cash-Flow Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.50 6.33 8.10 8.98 5.50

Competitive Comparison

For the Medical Distribution subindustry, China National Accord Medicines's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China National Accord Medicines Price-to-Operating-Cash-Flow Distribution

For the Medical Distribution industry and Healthcare sector, China National Accord Medicines's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where China National Accord Medicines's Price-to-Operating-Cash-Flow falls into.



China National Accord Medicines Price-to-Operating-Cash-Flow Calculation

China National Accord Medicines's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=34.09/5.24
=6.51

China National Accord Medicines's Share Price of today is ¥34.09.
China National Accord Medicines's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥5.24.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

China National Accord Medicines Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of China National Accord Medicines's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


China National Accord Medicines (SZSE:000028) Business Description

Traded in Other Exchanges
Address
No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029
China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.

China National Accord Medicines (SZSE:000028) Headlines

No Headlines